Replies to post #71205 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

(though NHS would later sign off on insurance coverage once they get the EMA MMA)

Please explain.

[pgsd]

The site you are talking about is noting items of interest.

Wrong, this is an online Report for brain cancer vaccine detailing information relating to medicines.

The ones in question are from the SEC form 10-K.is clearly stated.

Would you care to share where there is any mention about SEC form 10-K as you state it is clearly stated and I cannot find it anywhere.

http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4815

The comments are not "from the UK", they say nothing about what is going on in the UK.

As I said the comments are from this UK organisation that are affiliated to the UK NHS.

http://www.ukmi.nhs.uk/ukmi/about/default.asp?pageRef=1

And the date is simply when they were posted.

The date is when this particular entry was made as part of a chronological list of events relating to the treatment.

And approval over their is via the EU EMA, not NHS (though NHS would later sign off on insurance coverage once they get the EMA MMA).

This does not mean that important details about the treatment including approval would not be made to the NHS for many reasons. Also, another point on the AA or Fast track issue, below is another entry reiterating the NHS info definitely is {throughout the entire process} is gearing up to expect AA {they use your terminology in this example}

'Northwest Biotherapeutics will be able to petition the FDA for accelerated approval if the PII glioblastoma multiforme trial generates results consistent to those obtained from previous trials'